Paul Bullock - Replimune Chief Head
| REPL Stock | USD 6.95 0.39 5.95% |
Executive
Paul Bullock is Chief Head of Replimune Group
| Address | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
| Phone | 781 222 9600 |
| Web | https://www.replimune.com |
Replimune Management Efficiency
The company has return on total asset (ROA) of (0.2341) % which means that it has lost $0.2341 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4129) %, meaning that it created substantial loss on money invested by shareholders. Replimune's management efficiency ratios could be used to measure how well Replimune manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.25. The value of Return On Capital Employed is expected to slide to -0.27. At this time, Replimune's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 496.6 M this year, although the value of Non Currrent Assets Other will most likely fall to about 1.2 M.Management Performance
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.23 |
Replimune Group Leadership Team
Elected by the shareholders, the Replimune's board of directors comprises two types of representatives: Replimune inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Replimune. The board's role is to monitor Replimune's management team and ensure that shareholders' interests are well served. Replimune's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Replimune's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Coffin, President CEO, Director | ||
| Sushil Patel, Chief Officer | ||
| Colin Love, Chief Officer | ||
| Christopher Sarchi, Chief Officer | ||
| Tanya MS, Chief Officer | ||
| Philip FSA, Executive Chairman | ||
| Pamela Esposito, Chief Business Officer | ||
| Emily Hill, Chief Officer | ||
| Paul Bullock, Chief Head | ||
| Andrew Schwendenman, Chief Treasurer | ||
| MBA MD, Chief Officer | ||
| Jean Franchi, CFO, Officer |
Replimune Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Replimune a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.23 | ||||
| Current Valuation | 39.79 M | ||||
| Shares Outstanding | 61.39 M | ||||
| Shares Owned By Insiders | 5.79 % | ||||
| Shares Owned By Institutions | 94.21 % | ||||
| Number Of Shares Shorted | 8.34 M | ||||
| Price To Book | 1.04 X | ||||
| EBITDA | (177.4 M) | ||||
| Net Income | (174.28 M) |
Currently Active Assets on Macroaxis
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Replimune Stock analysis
When running Replimune's price analysis, check to measure Replimune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Replimune is operating at the current time. Most of Replimune's value examination focuses on studying past and present price action to predict the probability of Replimune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Replimune's price. Additionally, you may evaluate how the addition of Replimune to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Replimune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.16) | Return On Assets (0.23) | Return On Equity (0.41) |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.